Literature DB >> 11489895

Molecular characterization of the mouse Tem1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo.

R Opavsky1, P Haviernik, D Jurkovicova, M T Garin, N G Copeland, D J Gilbert, N A Jenkins, J Bies, S Garfield, S Pastorekova, A Oue, L Wolff.   

Abstract

Human tumor endothelial marker 1/endosialin (TEM1/endosialin) was recently identified as a novel tumor endothelial cell surface marker potentially involved in angiogenesis, although no specific function for this novel gene has been assigned so far. It was reported to be expressed in tumor endothelium but not in normal endothelium with the exception of perhaps the corpus luteum. Here we describe the cDNA and genomic sequences for the mouse Tem1/endosialin homolog, the identification and characterization of its promoter region, and an extensive characterization of its expression pattern in murine and human tissues and murine cell lines in vitro. The single copy gene that was mapped to chromosome 19 is intronless and encodes a 92-kDa protein that has 77.5% overall homology to the human protein. The remarkable findings are 1) this gene is ubiquitously expressed in normal human and mouse somatic tissues and during development, and 2) its expression at the mRNA level is density-dependent and up-regulated in serum-starved cells. In vitro, its expression is limited to cells of embryonic, endothelial, and preadipocyte origin, suggesting that the wide distribution of its expression in vivo is due to the presence of vascular endothelial cells in all the tissues. The ubiquitous expression in vivo is in contrast to previously reported expression limited to corpus luteum and highly angiogenic tissues such as tumors and wound tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489895     DOI: 10.1074/jbc.M105241200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities.

Authors:  Zhiliang Cheng; Ajlan Al Zaki; James Z Hui; Vladimir R Muzykantov; Andrew Tsourkas
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

Review 2.  Tumor endothelial cells.

Authors:  Andrew C Dudley
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

Review 3.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

4.  Endosialin expression in relation to clinicopathological and biological variables in rectal cancers with a Swedish clinical trial of preoperative radiotherapy.

Authors:  Zhi-Yong Zhang; Hong Zhang; Gunnar Adell; Xiao-Feng Sun
Journal:  BMC Cancer       Date:  2011-03-01       Impact factor: 4.430

5.  Development of 124I immuno-PET targeting tumor vascular TEM1/endosialin.

Authors:  Ann-Marie Chacko; Chunsheng Li; Madhura Nayak; John L Mikitsh; Jia Hu; Catherine Hou; Luigi Grasso; Nicholas C Nicolaides; Vladimir R Muzykantov; Chaitanya R Divgi; George Coukos
Journal:  J Nucl Med       Date:  2014-02-13       Impact factor: 10.057

6.  Cancer targeted therapeutics: From molecules to drug delivery vehicles.

Authors:  Daxing Liu; Debra T Auguste
Journal:  J Control Release       Date:  2015-09-02       Impact factor: 9.776

7.  The stromal cell antigen CD248 (endosialin) is expressed on naive CD8+ human T cells and regulates proliferation.

Authors:  Debbie L Hardie; Mathew J Baldwin; Amy Naylor; Oliver J Haworth; Tie Zheng Hou; Sian Lax; S John Curnow; Nick Willcox; John MacFadyen; Clare M Isacke; Christopher D Buckley
Journal:  Immunology       Date:  2011-04-06       Impact factor: 7.397

8.  CD248 facilitates tumor growth via its cytoplasmic domain.

Authors:  Margarida Maia; Astrid DeVriese; Tom Janssens; Michaël Moons; Rik J Lories; Jan Tavernier; Edward M Conway
Journal:  BMC Cancer       Date:  2011-05-08       Impact factor: 4.430

Review 9.  Characteristics of human Ewing/PNET sarcoma models.

Authors:  Beverly A Teicher; Rebecca G Bagley; Cecile Rouleau; Ariel Kruger; Yi Ren; Leslie Kurtzberg
Journal:  Ann Saudi Med       Date:  2011 Mar-Apr       Impact factor: 1.526

10.  CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models.

Authors:  Piyushkumar R Kapopara; Nooshin S Safikhan; Jenny L Huang; Scott C Meixner; Kevin Gonzalez; Houra Loghmani; Wolfram Ruf; Alan E Mast; Victor Lei; Edward L G Pryzdial; Edward M Conway
Journal:  J Thromb Haemost       Date:  2021-05-07       Impact factor: 16.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.